Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 7630 (117th)

Childhood Cancer STAR Reauthorization Act of 2022

referredUnited States· United States Congress· EN

Introduced

28 April 2022

Last action

29 April 2022 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. McCaul, Michael T. [R-TX-10], Rep. Speier, Jackie [D-CA-14], Rep. Butterfield, G. K. [D-NC-1], Rep. Kelly, Mike [R-PA-16], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Malinowski, Tom [D-NJ-7], Rep. Luria, Elaine G. [D-VA-2], Rep. Himes, James A. [D-CT-4], Rep. Kind, Ron [D-WI-3], Rep. Wild, Susan [D-PA-7], Rep. Ross, Deborah K. [D-NC-2], Rep. Neguse, Joe [D-CO-2], Rep. Posey, Bill [R-FL-8], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Allen, Rick W. [R-GA-12], Rep. Calvert, Ken [R-CA-41], Rep. Arrington, Jodey C. [R-TX-19], Rep. Emmer, Tom [R-MN-6], Rep. Bost, Mike [R-IL-12], Rep. Gallagher, Mike [R-WI-8], Rep. Cohen, Steve [D-TN-9], Rep. Mann, Tracey [R-KS-1], Rep. Wilson, Joe [R-SC-2], Rep. Connolly, Gerald E. [D-VA-11], Rep. Carbajal, Salud O. [D-CA-24], Rep. Bacon, Don [R-NE-2], Rep. Rutherford, John H. [R-FL-5], Mike Garcia, Rep. LaHood, Darin [R-IL-16], Rep. Lieu, Ted [D-CA-36], Rep. Meuser, Daniel [R-PA-9], Rep. Kuster, Ann M. [D-NH-2], Rep. Mace, Nancy [R-SC-1], Rep. Aguilar, Pete [D-CA-33], Rep. DeGette, Diana [D-CO-1], Rep. Garamendi, John [D-CA-8], Rep. Garbarino, Andrew R. [R-NY-2], Rep. Valadao, David G. [R-CA-22], Rep. Raskin, Jamie [D-MD-8], Rep. Lynch, Stephen F. [D-MA-8], Rep. Correa, J. Luis [D-CA-46], Rep. Williams, Roger [R-TX-25], Rep. Gonzales, Tony [R-TX-23], Rep. Auchincloss, Jake [D-MA-4], Rep. Crow, Jason [D-CO-6], Rep. Gooden, Lance [R-TX-5], Rep. Ruppersberger, C. A. Dutch [D-MD-2], Rep. Quigley, Mike [D-IL-5]

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Summary

Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act This bill reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 28 April 2022

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 28 April 2022

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 28 April 2022

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 29 April 2022

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 28 April 2022

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 28 April 2022

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 28 April 2022

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 111 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.